SARAJEVO (Bosnia and Herzegovina), January 27 (SeeNews) â Luxembourg-based Haden is offering for sale its 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] at an auction on January 29, the Sarajevo Stock Exchange (SASE) said.